Xin Ge

1.2k total citations · 1 hit paper
31 papers, 804 citations indexed

About

Xin Ge is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xin Ge has authored 31 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Xin Ge's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Xin Ge is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Xin Ge collaborates with scholars based in China and United States. Xin Ge's co-authors include Mingli Han, Dongwei Dou, Yuanting Gu, Liansheng Gong, Yuanting Gu, Guangcheng Guo, Xiaoyang Ren, Xinxing Wang, Xiaodong Xu and Zhang Cao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Biochemical Pharmacology and Experimental Cell Research.

In The Last Decade

Xin Ge

29 papers receiving 797 citations

Hit Papers

Breakthrough of solid tumor treatment: CAR-NK immunotherapy 2024 2026 2025 2024 20 40 60

Peers

Xin Ge
Ebru Alp Türkiye
Naser Jafari United States
Ga Bin Park South Korea
Yi Song China
Mudan Lu China
Jiehui Di China
Zhao Wu China
Xin Ge
Citations per year, relative to Xin Ge Xin Ge (= 1×) peers Claudia Geismann

Countries citing papers authored by Xin Ge

Since Specialization
Citations

This map shows the geographic impact of Xin Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Ge more than expected).

Fields of papers citing papers by Xin Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Ge. The network helps show where Xin Ge may publish in the future.

Co-authorship network of co-authors of Xin Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Ge. A scholar is included among the top collaborators of Xin Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Ge. Xin Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Bing, Xin Ge, Peijun Du, et al.. (2025). CREM-activated LTBP1 transcription promotes radioresistance and immune escape in triple-negative breast cancer. Biochemical Pharmacology. 241. 117172–117172.
2.
Chen, Qingqing, et al.. (2025). Recent advances and perspectives in biosynthesis of paclitaxel: key enzymes and intermediates. International Journal of Biological Macromolecules. 331(Pt 1). 148049–148049.
3.
Wang, Wenkang, Yang Liu, Zhen He, et al.. (2024). Breakthrough of solid tumor treatment: CAR-NK immunotherapy. Cell Death Discovery. 10(1). 40–40. 74 indexed citations breakdown →
4.
Shen, Xin, Xin Zhang, Kaiyu Li, et al.. (2024). Combined bacterial translocation and cholestasis aggravates liver injury by activation pyroptosis in obstructive jaundice. Heliyon. 10(16). e35793–e35793. 2 indexed citations
5.
Liu, Yangyang, Rui Xue, Xixi Duan, et al.. (2023). PARP inhibition synergizes with CD47 blockade to promote phagocytosis by tumor-associated macrophages in homologous recombination-proficient tumors. Life Sciences. 326. 121790–121790. 7 indexed citations
6.
Dou, Dongwei, Xiaoyang Ren, Mingli Han, et al.. (2020). CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis. Cancer Cell International. 20(1). 454–454. 79 indexed citations
7.
Ge, Xin, Jie Gao, Wei Deng, et al.. (2019). MiR‐34a inhibits the proliferation, migration, and invasion of oral squamous cell carcinoma by directly targeting SATB2. Journal of Cellular Physiology. 235(5). 4856–4864. 18 indexed citations
8.
Ge, Xin, et al.. (2019). NAMPT regulates PKM2 nuclear location through 14‐3‐3ζ: Conferring resistance to tamoxifen in breast cancer. Journal of Cellular Physiology. 234(12). 23409–23420. 24 indexed citations
9.
Li, Mengmeng, Dongmei Zhang, Xin Ge, et al.. (2019). TRAF6-p38/JNK-ATF2 axis promotes microglial inflammatory activation. Experimental Cell Research. 376(2). 133–148. 50 indexed citations
10.
Zhang, Yunsheng, Fang Li, Hongtao Jiang, et al.. (2019). Salinomycin triggers endoplasmic reticulum stress through ATP2A3 upregulation in PC-3 cells. BMC Cancer. 19(1). 381–381. 19 indexed citations
11.
Han, Mingli, Yimeng Wang, Li Lin, et al.. (2018). microRNA‐30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway. Journal of Cellular Biochemistry. 119(10). 8138–8145. 35 indexed citations
12.
Han, Mingli, Fang Wang, Yuanting Gu, et al.. (2016). MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG. Biomedicine & Pharmacotherapy. 80. 304–310. 39 indexed citations
13.
Yang, Chao, Xin Ge, Rong Zhang, et al.. (2016). Autologous bone marrow stem cell transplantation for the treatment of ulcerative colitis complicated with herpes zoster: a case report. Frontiers of Medicine. 10(4). 522–526. 4 indexed citations
14.
Ge, Xin, Yuanting Gu, Lin Li, et al.. (2015). Sonic hedgehog stimulates glycolysis and proliferation of breast cancer cells: Modulation of PFKFB3 activation. Biochemical and Biophysical Research Communications. 464(3). 862–868. 35 indexed citations
15.
Ge, Xin, et al.. (2015). Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting. Biochemical and Biophysical Research Communications. 463(4). 1115–1121. 71 indexed citations
16.
Ge, Xin, et al.. (2012). The G Protein-Coupled Receptor GPR30 Mediates the Nontranscriptional Effect of Estrogen on the Activation of PI3K/Akt Pathway in Endometrial Cancer Cells. International Journal of Gynecological Cancer. 23(1). 52–59. 42 indexed citations
17.
Ge, Xin, et al.. (2011). Rhein induces apoptosis of HCT-116 human colon cancer cells via activation of the intrinsic apoptotic pathway. AFRICAN JOURNAL OF BIOTECHNOLOGY. 10(61). 13244–13251. 8 indexed citations
18.
Wang, Shaohua, Zhihui Deng, Qi Li, et al.. (2011). A novel alkaline serine protease with fibrinolytic activity from the polychaete, Neanthes japonica. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 159(1). 18–25. 28 indexed citations
19.
Wang, Shaohua, Qi Li, Zhihui Deng, et al.. (2010). Neanthes japonica (Iznka) fibrinolytic enzyme reduced cerebral infarction, cerebral edema and increased antioxidation in rat models of focal cerebral ischemia. Neuroscience Letters. 489(1). 16–19. 10 indexed citations
20.
Wang, Yong, et al.. (2009). Acetylcholinesterase inhibitor is a potentially useful therapeutic agent for nicotine-induced periodontal disease. Medical Hypotheses. 73(4). 604–605. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026